Outcome of DOJ lawsuit against Walgreens in Chicago by end of 2025?
Settlement • 25%
Trial verdict in favor of DOJ • 25%
Trial verdict in favor of Walgreens • 25%
Case dismissed • 25%
Publicly available court records and official announcements from the court or involved parties
DOJ Files 300-Page Lawsuit in Chicago Against Walgreens for Role in Opioid Crisis Since August 2012
Jan 17, 2025, 10:37 PM
The U.S. Department of Justice has filed a 300-page civil lawsuit against Walgreens in the U.S. District Court in Chicago, alleging that the pharmacy chain knowingly filled millions of prescriptions for opioids and other controlled substances that lacked a legitimate medical purpose from August 2012 until the present. The lawsuit claims that Walgreens pharmacists filled these prescriptions despite clear red flags indicating their unlawfulness, contributing to the U.S. opioid crisis. The DOJ asserts that Walgreens pressured its pharmacists to fill prescriptions quickly without confirming their validity, using metrics such as 'Verify By Promise Time' (VBPT), which expected a prescription to be filled within 15 minutes, and the 'Non-dispensing Pharmacist Report' to track pharmacists dispensing low rates of controlled substances. This pressure led to the illegal distribution of millions of opioid pills. Some Walgreens patients reportedly died of overdose deaths shortly after receiving these invalid prescriptions. Walgreens has responded by seeking court clarification on the responsibilities of pharmacies and pharmacists, arguing against what it perceives as arbitrary rules enforced by the government. The company also defends its pharmacists, stating they fill legitimate prescriptions in accordance with applicable laws and regulations. The lawsuit follows similar actions against other major pharmacy chains, highlighting ongoing efforts to address the opioid epidemic.
View original story
Settlement reached • 25%
Walgreens wins • 25%
Case dismissed • 25%
DOJ wins • 25%
Other changes • 25%
New prescription verification policies • 25%
Increased pharmacist training • 25%
No significant changes • 25%
No change in market share • 25%
Increased market share • 25%
Decreased market share • 25%
Uncertain impact • 25%
Ongoing litigation • 25%
CVS found liable • 25%
CVS settles • 25%
Case dismissed • 25%
Other outcome • 25%
CVS found guilty • 25%
Case dismissed • 25%
CVS found liable • 25%
CVS not liable • 25%
CVS settles • 25%
CVS found liable • 25%
CVS not found liable • 25%
Case dismissed • 25%
Settlement reached • 25%
None of the above • 25%
Walgreens • 25%
Rite Aid • 25%
Walmart • 25%
Sale to another party • 25%
Sale abandoned • 25%
Sale completed • 25%
No sale • 25%
Sale completed • 33%
Negotiations extended • 34%
Negotiations fail • 33%
No penalty • 25%
$1 billion to $5 billion • 25%
Less than $1 billion • 25%
More than $5 billion • 25%